|
Aclasta in Bangladesh
Dhaka, January 19, 2008 -
Aclasta was launched in Bangladesh where the prevalence of
Postmenopausal Osteoporosis is increasing.
To ensure the best possible results with the introduction in
the Bangladesh market, Novartis implemented a crash program
addressing the opportunities that included the following
actions:
Aclasta Go To Launch Training
for Aclasta Team, held on December 17th, 2007, prior to
introducing the product.
The training covered disease, product, patients, A2B model
call and key messages to be given.
Aclasta International Seminar
"Aclasta: A new approach to manage Osteoporosis", held on
January 16th, 2008, at the Bangladesh China Friendship
Conference Center.
Dr. Erik Fink Eriksen, Global Brand Medical Director of
Aclasta, was the key note speaker of the event, where top
Rheumatologists, Orthopedicians, Gynecologists,
Endocrinologists and Physical Medicine Specialists were
present.
Aclasta Launch Meeting,
held on January 19th, 2008 at the Bangladesh China
Friendship Conference Center, with the participation of all
the field colleagues'.
A tracking tool has been rolled out to track field
colleagues'
performance by product managers called FLM & FF himself.
|
|
About Novartis
Novartis is a world leader in offering medicines to protect
health, treat diseases and improve well-being. Our goal is
to discover, develop and successfully market innovative
products to treat patients, ease suffering and enhance the
quality of life. Novartis is the only company with
leadership positions in both patented and generic
pharmaceuticals (Sandoz). We are strengthening our
medicine-based portfolio, which is focused on strategic
growth platforms in innovation-driven pharmaceuticals, high
quality and affordable generics (Sandoz), human vaccines and
leading self-medication OTC brands. Headquartered in Basel,
Switzerland, Novartis Group companies employ more than
100,000 people and operate in over 140 countries around the
world.
Novartis has manufacturing and marketing operations in
Bangladesh since 1973 in areas of Research, Off Patent
Branded Generic (Sandoz) and OTC Pharmaceuticals along with
Animal Health.
###
Novartis
(Bangladesh) Limited Media Relations
Rasna Hasan
Head of Corporate Affairs and
Communication
Novartis (Bangladesh) limited
House 50, Road 2A
Dhanmondi RA
Dhaka 1209
BANGLADESH
+880 2 8615302-8
rasna.hasan@sandoz.com
The information in the
media releases on these pages was factually accurate on the
date of publication. These media releases remain on Novartis
website for historical purposes only. Novartis assumes no
duty to update the information to reflect subsequent
developments. Readers should not rely upon the information
in these pages as current or accurate after their
publication dates.
|
